[1]
Pinky Karam et al. 2022. Determination of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients. Current Aspects in Pharmaceutical Research and Development Vol. 9. (Feb. 2022), 56–69. DOI:https://doi.org/10.9734/bpi/caprd/v9/2472C.